5′-Phosphate and 5′-Phosphonate Ester Derivatives of (N)-Methanocarba Adenosine with in Vivo Cardioprotective Activity
- 3 January 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (3) , 902-914
Abstract
Activation of a cardiac myocyte P2X4 receptor protects against heart failure. 5′-Phosphonate and 5′-phosphate analogues of AMP containing a (N)-methanocarba (bicyclo[3.1.0]hexane) system could protect from heart failure by potentially activating this cardioprotective channel. Phosphoesters and phosphonodiesters were synthesized and administered in vivo via a miniosmotic pump in a mouse ischemic heart failure model and most significantly increased intact heart contractile function (echocardiography) compared to vehicle infusion. Several new thio and deuterated phosphate derivatives were protective in a calsequestrin (CSQ) overexpressing heart failure model. Diethyl (7, MRS4084) and diisopropyl (8, MRS4074) phosphotriesters were highly protective in the ischemic model. Substitution of 2-Cl with iodo reduced protection in the CSQ model. Diisopropyl ester 16 (MRS2978) of (1′S,2′R,3′S,4′R,5′S)-4′-(6-amino-2-chloropurin-9-yl)-2′,3′-(dihydroxy)-1′-(phosphonoethylene)bicyclo[3.1.0]hexane was highly efficacious (CSQ), while lower homologue 1′-phosphonomethylene derivative 14 was inactive. Thus, we identified uncharged carbocyclic nucleotide analogues that represent potential candidates for the treatment of heart failure, suggesting this as a viable and structurally broad approach.Keywords
This publication has 23 references indexed in Scilit:
- Capture hydrolysis signals in the microsomal stability assay: Molecular mechanisms of the alkyl ester drug and prodrug metabolismBioorganic & Medicinal Chemistry Letters, 2012
- Activation and Regulation of Purinergic P2X Receptor ChannelsPharmacological Reviews, 2011
- Treatment of Heart Failure by a Methanocarba Derivative of Adenosine Monophosphate: Implication for a Role of Cardiac Purinergic P2X ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Structure−Activity Relationship of (N)-Methanocarba Phosphonate Analogues of 5′-AMP as Cardioprotective Agents Acting Through a Cardiac P2X ReceptorJournal of Medicinal Chemistry, 2010
- Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell lineAmerican Journal of Physiology-Cell Physiology, 2008
- Role of P2X purinergic receptors in the rescue of ischemic heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractilityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Derivatives of tramadol for increased duration of effectBioorganic & Medicinal Chemistry Letters, 2006
- Extension and revision of the von Baeyer system for naming polycyclic compounds (including bicyclic compounds)Pure and Applied Chemistry, 1999